The King’s Fund’s Anna Dixon joins Department of Health
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dixon, NHS, king's fund
Director of Policy at The King’s Fund Dr Anna Dixon will be joining the Department of Health in early May …
Ben Goldacre versus Stephen Whitehead – PharmaTimes Debate
February 27, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BMJ, Bad pharma, Cochrane, Goldacre, Whitehead
In the end, the ‘head to head’ between the UK’s most high profile critic of the pharma industry and ABPI …
Merck suffers brain cancer reverse
February 26, 2013Sales and Marketing Merck, cilengitide
Merck’s oncology programme has suffered a setback as a Phase III trial of its investigational integrin inhibitor cilengitide failed in …
Probe launched as deaths prompt Omontys recall
February 26, 2013Manufacturing and Production Affymax, Takeda, omontys, recall
Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …
Elan sceptical of Royalty
February 26, 2013Sales and Marketing Elan, FDA, Tysabri, royalty pharma
Elan Corporation has poured tepid water on private equity firm Royalty Pharma’s putative offer this week for the Irish biotech …
Pharma manufacturing news in brief
February 26, 2013Manufacturing and Production Baxter International, Bone Therapeutic, DSM Pharmaceutical Products and Chemtrix, Sovereign Pharmaceutical
Sovereign Pharma rapped by FDA, facility updates from Bone Therapeutics, Baxter and SHL, plus a continuous processing alliance between DSM …
Abbott, GSK cut staff at Irish facilities
February 26, 2013Manufacturing and Production Abbottt, GSK, Ireland
GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …
Continuous processing production line set up in Finland
February 25, 2013Manufacturing and Production Finland, PROMIS
A specialist centre in Finland providing expertise in the continuous processing of pharmaceuticals, first envisaged in 2008, opened its doors …
Pharmalink Consulting appoints five consultants
February 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting
Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …
Abbott seeks leukemia test
February 25, 2013Sales and Marketing AbbVie, Abbott, Janssen
Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …
FDA approves Kadcyla
February 25, 2013Herceptin, Roche, T-DM1
Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …
$33m prizes for research
February 22, 2013Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google
Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …
Ariad expands in Europe
February 22, 2013Sales and Marketing Ariad, leukaemia, leukemia
The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …
Roche censured for drunken conference antics
February 21, 2013Medical Communications, Sales and Marketing ABPI, PMCPA, Roche
The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …
Watson: the supercomputer revolution begins here
February 21, 2013Medical Communications Watson, ibm
Watson, a supercomputer developed by IBM is to make its debut helping oncologists diagnose and choose the best treatment for …
John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency
You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …
Pharma losing in ‘valley of death’
February 21, 2013Research and Development, Sales and Marketing Bath, Evotec, pharma
An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …
Lundbeck elects new chairman
February 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck
Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …
SHL to invest 40 Million USD in 2013 to significantly expand production facilities
February 21, 2013Manufacturing and Production auto injectors, autoinjector, drug delivery, pen injectors
SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices …
NHS Confederation appoints two directors
February 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation
The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
